Insulin sensitivity, glucose effectiveness, and β-cell function in obese males with essential hypertension: Investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin- converting enzyme inhibitor (quinapril)

Metabolism: Clinical and Experimental

Volumn 46, Issue 2, 1997, Pages 173-178

  Cabezas Cerrato, José ^a   Garcia Estevez, Daniel A ^b   Araújo, David ^b   Iglesias, Manuel ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN; QUINAPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031040819     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90298-5     Document Type: Article

References (54)

1. DeFronzo RA: The triumvirate: β-Cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687, 1987
2. Rabinowitz TZ, Zierler KL: Forearm metabolism in obesity and its responses to intra-arterial insulin. Characteristics of insulin resistance and evidence for adaptative hyperinsulinism. J Clin Invest 41:2163-2171, 1962
3. Ginsberg H, Kimmerling G, Olefsky JM, et al: Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest 55:454-461, 1975
4. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
5. Modan M, Halkin H, Almog S, et al: Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
6. Capaldo B, Lembo G, Napoli R, et al: Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 40:1320-1322, 1991
7. Natali A, Santoro D, Palombo C, et al: Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 17:170-178, 1991
8. The Working Group on Hypertension in Diabetes: Statement on hypertension in diabetes mellitus. Arch Intern Med 147:830-842, 1987
9. Pollare T, Lithel H, Selinus I, et al: Sensitivity to insulin during treatment with atenolol and metoprolol: A randomized, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med 1298:1152-1157, 1989
10. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-873, 1989
11. Pollare T, Lithel H, Selinus I, et al: Application of prazosin is associated with increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31:415-420, 1988
12. Draznin B, Sussman KE, Eckel RH, et al: Possible role of cytosolic free calcium concentration in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 82:1848-1852, 1988
13. Foot EA, Leighton B: Effects of calcium antagonists on insulin-mediated glucose metabolism in skeletal muscle. Diabetes 43:73-79, 1994
14. Pollare T, Lithell H, Morlin C, et al: Metabolic effects of diltiazem and atenolol: Results from a randomized, double blind study with parallel groups. J Hypertens 7:551-559, 1989
15. Pershadsingh HA, Grant N: Association of diltiazem therapy with increased insulin resistance in patients with type I diabetes mellitus. JAMA 257:931-932, 1987
16. Moller DE, Flier JS: Insulin resistance: Mechanism, syndromes, and implications. N Engl J Med 26:938-948, 1991
17. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
18. Warran JH, Martic BC, Krolewski AS, et al: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Ann Intern Med 113:909-915, 1990
19. Ho LT, Chang ZY, Wang JT, et al: Insulin insensitivity in offspring of parents with type 2 diabetes mellitus. Diabet Med 7:31-34, 1990
20. Cabezas-Cerrato J, Araúxo D, García-Estévez DA, et al: Endocrine/metabolic markers in NIDDM. Diabetologia 36:A178, 1993 (suppl 1, abstr)
21. Ferrari P, Weidmann P, Shaw S, et al: Altered insulin sensitivity, hyperinsulinemia, and dyslipemia in individuals with a hypertensive parent. Am J Med 91:589-596, 1991
22. Widgren BR, Urbanavicius V, Attvall S, et al: Insulin sensitivity is more related to fat distribution than to heredity for hypertension in normotensive men. Metabolism 43:883-886, 1994
23. Jarret RJ, Baken IA, Keen H, et al: Diurnal variation in oral glucose tolerance, blood sugar and plasma insulin levels in the morning, afternoon and evening. Br Med J 1:199-201, 1972
24. Carroll KF, Nestel PL: Diurnal variation in glucose tolerance and insulin secretion in man. Diabetes 22:333-348, 1973
25. Lee A, Ader M, Bray GA, et al: Diurnal variation in glucose tolerance. Cyclic suppression in insulin action and insulin secretion in normal-weight, but not obese subjects. Diabetes 41:750-759, 1992
26. Bergman RN, Ider YZ, Bowden CR, et al: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
27. Bergman RN: Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38:1512-1527, 1989
28. Araúxo D, Camarero E, Iglesias M, et al: Insulin sensitivity in non insulin dependent diabetes mellitus and obesity using the minimal model approach. Importance of early insulin secretion on carbohydrate tolerance, in Crepaldi G, Tiengo A, Enzy G (eds): Diabetes, Obesity and Hyperlipemias, vol 4. Amsterdam, The Netherlands, Elsevier Science, 1990, pp 211-213
29. ZXSSO. Houston, TX, International Mathematical Subroutine Library, 1982
30. Brown KM, Dennis JE: Derivative free analogues of the Levenberg-Marquardt and Gauss algorithms for non linear least squares approximations. Numerische Mathematik 18:289-297, 1992
31. Pacini G, Bergman RN: MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
32. Prigeon RL, Kahn SE, Porte D Jr: Reliability of error estimates from minimal model: Implications for measurements in physiological studies. Am J Physiol 266:E279-E286, 1994
33. Bonora E, Bonadonna RC, Del Prato S, et al: In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension. Diabetes 42:764-772, 1993
34. Bonora E, Moghetti P, Zenere M, et al: B cell secretion and insulin sensitivity in hypertensive and normotensive obese subjects. Int J Obes 14:735-742, 1990
35. O'Shaughnessy IM, Myers TJ, Stepniakowski K, et al: Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension 26:186-192, 1995
36. Istfan NW, Plaisted CS, Bistrian BR, et al: Insulin resistance versus insulin secretion in the hypertension of obesity. Hypertension 19:385-392, 1992
37. Maheux P, Jeppesen J, Sheu WHH, et al: Additive effects of obesity, hypertension and type 2 diabetes on insulin resistance. Hypertension 24:695-698, 1994
38. Welch S, Gebhart SSP, Bergman RN, et al: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
39. Araújo D, García-Estévez DA, Cabezas-Cerrato J: Importance of glucose effectiveness on glucose tolerance in obese people. Int J Obes 20:87A, 1996 (suppl 4, abstr)
40. Bergman RN, Phillips L, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467, 1981
41. Lind L, Berne C, Lithell H: Prevalence of insulin resistance in essential hypertension. J Hypertens 13:1457-1462, 1995
42. Cabezas-Cerrato J, García-Estévez DA, Araújo D, et al: Beta cell glucose sensitivity and peripheral insulin resistance in essential hypertension. Diabetologia 37:554A, 1994 (suppl 1, abstr)
43. Manicardi V, Camellini L, Bellodi G, et al: Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 62:1302-1304, 1986
44. Grugni G, Ardizzi A, Dubini A, et al: No correlation between insulin levels and high blood pressure in obese subjects. Horm Metab Res 22:124-125, 1990
45. Sechi LA, Tedde R, Marigliano A, et al: Insulin resistance and β-cell hypersecretion in essential hypertension. J Hypertens 8:S87-S89, 1990 (suppl 4)
46. Kahn SE, Pringeon RL, McCulloch DK, et al: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
47. Lerner RL, Porte D: Acute and steady state insulin responses to glucose in nonobese diabetic subjects. J Clin Invest 51:1624-1631, 1972
48. Santoro D, Natali A, Palombo C, et al: Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension 20:181-191, 1992
49. +2 channel antagonists, and alfaadrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes 44:665-671, 1995
50. Pardell H: Blood Hypertension as a Problem of a Community in Spain (ed 2). Madrid, Spain, Liga Española para la Lucha contra la Hipertension Arterial, 1986, pp 1-15
51. Bianchi S, Bigazzi R, Quiñones Galvân A, et al: Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension 26:789-795, 1995
52. Sharma AM, Ruland K, Spies KP, et al: Salt sensitivity in young normotensive subjects associated with a hyperinsulinemic response to oral glucose. J Hypertens 9:329-335, 1991
53. Sharma AM, Schorr U, Distler A: Insulin resistance in young salt-sensitive normotensive subjects. Hypertension 21:273-279, 1993
54. Egan BM, Stepniakowski K, Nazzaro P: Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension 23:11-17, 1994 (suppl 1)